FDA 483 - Rush University Medical Center IRB - September 12, 2025

Rush University System for Health IRB in Chicago, IL, was inspected by the FDA, revealing a significant deficiency in their informed consent process. The IRB failed to ensure that informed consent documents for multiple studies included a statement notifying participants of the possibility of FDA record inspection. This indicates a compliance issue related to human subject protection regulations.